At a glance
ClinicalIndex Comparison Record- ✓Age 19-45 years
- ✓All 12 anterior teeth present (canine to canine in both upper and lower arches)
- ✓Apparently healthy with no history of cardiovascular disease
- ✓English speaking
- ✕Taking aspirin, NSAIDs, or statins
- ✕Pregnant or nursing women
- ✕Women taking birth control pills or using hormone-releasing contraceptive devices
- ✕Women on hormone replacement therapy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial of Plaque Identifying Toothpaste on Reduction of Plaque and Inflammation
In Brief
A clinical study evaluating Plaque identifying toothpaste and Non-plaque identifying toothpaste for Plaque and Inflammation. Completed, enrolled 61 participants across 1 site.
Detailed Summary
Dental plaque causes caries and periodontal disease and data are sparse about toothpaste and plaque removal. Inflammation, caused by dental plaque, is a risk factor for cardiovascular disease. (CVD) The availability of (Plaque HD (TM), a plaque identifying toothpaste with targetol technology (TM)), afforded the unique opportunity to test whether there were statistically significant and clinically important reductions in plaque and inflammation in a randomized trial of apparently healthy individuals.
Study Details
Timeline
Interventions
Plaque identifying toothpaste with targetol
Non-plaque identifying toothpaste without targetol